Thinning of Macular Neuroretinal Layers Contributes to Sleep Disorder in Patients With Type 2 Diabetes Without Clinical Evidences of Neuropathy and Retinopathy

Abstract

Aims: To investigate the impact of thinning at individual grids of macular neuroretinal layers, clinical factors, and inadequate light exposure on the specific components of sleep disorder in patients with type 2 diabetes.Methods: One hundred twenty-four patients with type 2 diabetes without clinical evidences of diabetic retinopathy and neuropathy (HbA1c: 8.3%, diabetes duration; 8.7 years) and 54 age-and sex-matched control subjects (HbA1c: 5.6%) underwent detailed clinical, neurological, and ophthalmological examinations. The sleep disorder was assessed by the Pittsburgh Sleep Quality Index Japanese Version (PSQI-J). The temporal structures of daily life were assessed by the Munich Chronotype Questionnaire Japanese Version. The thickness at nine grids defined by the Early Treatment Diabetic Retinopathy Study of nine macular neuroretinal layers was determined by swept-source optical coherence tomography and OCT-Explorer. The associations between the individual components of sleep disorders and the thickness at each grid of macular neuroretinal layers, clinical factors, or the temporal structures of daily life were examined.Results: The prevalence of the sleep disorder, global score, and four individual PSQI-J scores in patients with type 2 diabetes were higher than control subjects. The thickness of two and five grids of two inner retinal layers and four to seven grids of four outer retinal layers in patients with type 2 diabetes was thinner than those in control subjects. The thickness at one to eight grids of four outer retinal layers in type 2 diabetic patients was inversely associated with global score and five individual scores of sleep disorder. The thinning at one to two grids of the inner plexiform layer was related to three high individual scores of sleep disorder. The inappropriate light exposure was associated with the sleep disorder and altered macular neuroretinal layers. The high HbA1c and LDL-cholesterol levels were related to the high global score and two individual scores of sleep disorder, respectively. Ishibashi and Tavakoli Neuroretinal Alterations and Sleep DisorderConclusion: In patients with type 2 diabetes, the thinning at grids of the inner plexiform layer and outer retinal layers was associated with the high scores of specific components of the sleep disorder. The sleep disorder was also related to hyperglycemia, dyslipidemia, and inappropriate light exposure. Keywords: inappropriate light exposure, optical coherence tomography, Pittsburgh sleep quality index Japanese version, sleep disorder, thinning of macular neuroretinal layer, type 2 diabetes Abbreviations: ETDRS, Early Treatment Diabetic Retinopathy Study; GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; IS/OS, junction of inner and outer segment of photoreceptor; OCT, optical coherence tomography; ONL, outer nuclear layer; OPL, outer plexiform layer; OPR, outer segment of photoreceptor/retinal pigment epithelium complex; PSQI-J, Pittsburgh Sleep Quality Index Japanese Version; RNFL, retinal nerve f...

The Impact of Glycemic Control on Retinal Photoreceptor Layers and Retinal Pigment Epithelium in Patients With Type 2 Diabetes Without Diabetic Retinopathy: A Follow-Up Study

“…The thickness and reflectance in patients with diabetes seem to be variable compared with those in control subjects. The metrics of MPRLs and RPE are influenced by not only glycemic levels (28), but also many clinical factors including anthropometric values, blood pressure and serum lipid levels (22). In control subjects, these clinical factors were stable and existed in a narrow range during the follow-up period, while in the present study all values in patients except for BMI were significantly different between baseline and endpoint.…”

“…The mean thickness of 6 grids of interdigitation zone and one grid of RPE in patients was thinner than controls (22). Glycemic control did not restore the thickness of interdigitation zone and RPE.…”

The role of lutein-rich purple sweet potato leaf extract on the amelioration of diabetic retinopathy in streptozotocin-induced Sprague–Dawley rats

“…This is mainly because the accumulation of lactate in the hyperglycemic condition and retinal hypoxia stimulates the blood vessel of the retina, which increases the diameter (Klein et al, 2011) and makes it prone to microvascular damage, probably reducing the overall thickness of the retina over time and causing severe central vision loss (Alghadyan, 2011), as shown in the DNS group. Thus, this altered neuroretinal degeneration further enhances the thinning of OLN (Ishibashi and Tavakoli, 2020) in the DNS group. In the bargain, in diabetes, an excess glucose level in aqueous humor stimulates aldose reductase, a catalyzing enzyme that converts glucose to sorbitol.…”

Association of serum apolipoprotein B with retinal neurovascular structural alterations in patients with type 2 diabetes: an optical coherence tomography angiography study

“…(5) patients with no previous treatment with intravitreal injections or laser photocoagulation; (6) patients with no prior history of vitreoretinal surgery, uveitis or other retinal diseases; (7) patients with no history of glaucoma or coexisting neuro-ophthalmic diseases; and (8) patients with an axis length (AL) < 25 mm. The exclusion criteria included active inflammation, infectious disease, hypertension (systolic blood pressure > 130 mmHg and/or diastolic blood pressure > 85 mmHg), history of atherosclerosis, stroke or malignancy and any patients with ocular conditions that affect OCTA imaging (scan quality < 9, e.g., advanced cataract).…”

“…Multiple studies in several countries have confirmed that dyslipidemia is an important risk factor for diabetic retinopathy [5], and serum low-density lipoprotein cholesterol (LDL-C) levels are associated with an increased risk for progression to advanced retinopathy [6] and retinal neurovascular impairment in diabetic patients [7]. ApoB is the principal lipoprotein component of LDL-C [8], and abnormal metabolism of apoB is regarded as an important feature of diabetic dyslipidemia [9].…”